Status:

UNKNOWN

Celiprolol Versus Ditiazem for the Prevention of Postoperative Cardiac Arrythmias in Thoracic Surgery

Lead Sponsor:

Abderrahmane Mami Hospital

Conditions:

Postoperative Cardiac Complication

Eligibility:

All Genders

18-80 years

Phase:

PHASE2

Brief Summary

Cardiac arrythmias are the most common cardiac complications after thoracic surgery. They are made primarily of postoperative atrial fibrillation (POAF). They are associated with an increased risk of...

Detailed Description

Cardiac arrythmias are the most common cardiac complications after thoracic surgery. They are made primarily of postoperative atrial fibrillation (POAF). They are associated with an increased risk of...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years Sinus rhythm preoperatively.
  • Surgery at high risk of atrial arrhythmia occurring postoperatively:
  • Bi-lobectomy
  • Pneumonectomie

Exclusion

  • Signs of myocardial ischemia per or post operative.
  • Persistent postoperative hypotension requiring the use of catecholamines.
  • Persistent bradycardia
  • Decompensated cardiac insufficiency.
  • Acute intestinal obstruction.

Key Trial Info

Start Date :

December 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2020

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT03752931

Start Date

December 1 2018

End Date

December 1 2020

Last Update

November 26 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Abderrahmane Mami

Aryanah, Tunisia